SCHEMBL5560773

SCHEMBL5560773

CC(F)c1ccc(O)nc1CC(N)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.41
PTGS1 P23219 2/20 0.39
PKM P14618 2/20 0.39
ALPI P09923 1/20 0.39
XIAP P98170 1/20 0.39
GRIA2 P42262 3/20 0.38
GRIA1 P42261 2/20 0.38
GRIA3 P42263 2/20 0.38
GRIA4 P48058 2/20 0.38
HSD17B10 Q99714 3/20 0.38
USP2 O75604 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALOX15 P16050 2/20 0.38
RECQL P46063 2/20 0.38
HIF1A Q16665 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
EGFR P00533 1/20 0.38
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5560872 0.77 CYP1A2 (0.46) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL5560784 0.77 SLC7A5 (0.42) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL5560778 0.74 SLC7A5 (0.41) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL5561205 0.73 USP2 (0.40) SLC7A5PTGS1PKMGRIA2GRIA1
SCHEMBL5565679 0.72 KDM4E (0.50) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL5565851 0.70 NOS3 (0.54) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL5566266 0.70 KDM4E (0.50) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL5566972 0.69 HSD17B10 (0.40) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL5560804 0.67 CYP1A2 (0.50) SLC7A5PTGS1PKMALPIXIAP
SCHEMBL9952991 0.66 CYP1A2 (0.57) SLC7A5PTGS1PKMALPIXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189383-B2 Radioactively labelled amino acid analogues, their preparation and use MALLINCKRODT INC. 2007-03-13 US claimed
US-20060127306-A1 Radioactively labelled amino acid analogues, their preparation and use VRIJE UNIVERSITEIT BRUSSEL (BE) 2006-06-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060127306-A1 Radioactively labelled amino acid analogues, their preparation and use BCAT1, BCAT2, SLC1A5 SLC7A5 8/4885PTGS1 2264/4885PKM 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.